English
简体中文
Total: £ 56.28
Published Date: 2025-10-15 | Pages: 126 | Tables: 123 | Medical Care
The global Single Base Editor market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
The single base editor is an innovative genome editing tool that can efficiently catalyze base conversion without producing DNA double-strand breaks or requiring a donor DNA template. The basic principle is to convert cytosine deaminase ( APOBEC) or adenosine deaminase is formed by fusion with the existing Cas9n (D10A), relying on the CRISPR principle to modify a single base at positions 4-7 away from the PAM end of the target. Currently, there are two types of base editors widely used: adenine base editor (ABE) and cytosine base editor (CBE). They have shown great achievements in basic research, gene therapy, animal and plant breeding improvement and other fields. application value.
From a downstream perspective, Gene Therapy accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Single Base Editor leading manufacturers including Beam Therapeutics, Verve, Intellia, Prime Medicine, CRISPR, GenKOre, Genassisttx, HuidaGene, CorrectSequence Therapeutics, etc., dominate supply; the top five capture approximately % of global revenue, with Beam Therapeutics leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Single Base Editor market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Beam Therapeutics
Verve
Intellia
Prime Medicine
CRISPR
GenKOre
Genassisttx
HuidaGene
CorrectSequence Therapeutics
Segment by Type
Adenine Base Editor
Cytosine Base Editor
Other
Segment by Application
Gene Therapy
Animal and Plant Breeding Improvement
Basic Research
Other
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Single Base Editor study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Single Base Editor: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Single Base Editor Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Adenine Base Editor
1.2.3 Cytosine Base Editor
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Single Base Editor Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Gene Therapy
1.3.3 Animal and Plant Breeding Improvement
1.3.4 Basic Research
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Single Base Editor Revenue Estimates and Forecasts 2020-2031
2.2 Global Single Base Editor Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Single Base Editor Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Single Base Editor Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Adenine Base Editor Market Size by Players
3.3.2 Cytosine Base Editor Market Size by Players
3.3.3 Other Market Size by Players
3.4 Global Single Base Editor Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Single Base Editor Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Single Base Editor Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Single Base Editor Market Size by Type (2020-2031)
6.4 North America Single Base Editor Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Single Base Editor Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Single Base Editor Market Size by Type (2020-2031)
7.4 Europe Single Base Editor Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Single Base Editor Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Single Base Editor Market Size by Type (2020-2031)
8.4 Asia-Pacific Single Base Editor Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Single Base Editor Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Single Base Editor Market Size by Type (2020-2031)
9.4 Central and South America Single Base Editor Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Single Base Editor Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Single Base Editor Market Size by Type (2020-2031)
10.4 Middle East and Africa Single Base Editor Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Single Base Editor Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Beam Therapeutics
11.1.1 Beam Therapeutics Corporation Information
11.1.2 Beam Therapeutics Business Overview
11.1.3 Beam Therapeutics Single Base Editor Product Features and Attributes
11.1.4 Beam Therapeutics Single Base Editor Revenue and Gross Margin (2020-2025)
11.1.5 Beam Therapeutics Single Base Editor Revenue by Product in 2024
11.1.6 Beam Therapeutics Single Base Editor Revenue by Application in 2024
11.1.7 Beam Therapeutics Single Base Editor Revenue by Geographic Area in 2024
11.1.8 Beam Therapeutics Single Base Editor SWOT Analysis
11.1.9 Beam Therapeutics Recent Developments
11.2 Verve
11.2.1 Verve Corporation Information
11.2.2 Verve Business Overview
11.2.3 Verve Single Base Editor Product Features and Attributes
11.2.4 Verve Single Base Editor Revenue and Gross Margin (2020-2025)
11.2.5 Verve Single Base Editor Revenue by Product in 2024
11.2.6 Verve Single Base Editor Revenue by Application in 2024
11.2.7 Verve Single Base Editor Revenue by Geographic Area in 2024
11.2.8 Verve Single Base Editor SWOT Analysis
11.2.9 Verve Recent Developments
11.3 Intellia
11.3.1 Intellia Corporation Information
11.3.2 Intellia Business Overview
11.3.3 Intellia Single Base Editor Product Features and Attributes
11.3.4 Intellia Single Base Editor Revenue and Gross Margin (2020-2025)
11.3.5 Intellia Single Base Editor Revenue by Product in 2024
11.3.6 Intellia Single Base Editor Revenue by Application in 2024
11.3.7 Intellia Single Base Editor Revenue by Geographic Area in 2024
11.3.8 Intellia Single Base Editor SWOT Analysis
11.3.9 Intellia Recent Developments
11.4 Prime Medicine
11.4.1 Prime Medicine Corporation Information
11.4.2 Prime Medicine Business Overview
11.4.3 Prime Medicine Single Base Editor Product Features and Attributes
11.4.4 Prime Medicine Single Base Editor Revenue and Gross Margin (2020-2025)
11.4.5 Prime Medicine Single Base Editor Revenue by Product in 2024
11.4.6 Prime Medicine Single Base Editor Revenue by Application in 2024
11.4.7 Prime Medicine Single Base Editor Revenue by Geographic Area in 2024
11.4.8 Prime Medicine Single Base Editor SWOT Analysis
11.4.9 Prime Medicine Recent Developments
11.5 CRISPR
11.5.1 CRISPR Corporation Information
11.5.2 CRISPR Business Overview
11.5.3 CRISPR Single Base Editor Product Features and Attributes
11.5.4 CRISPR Single Base Editor Revenue and Gross Margin (2020-2025)
11.5.5 CRISPR Single Base Editor Revenue by Product in 2024
11.5.6 CRISPR Single Base Editor Revenue by Application in 2024
11.5.7 CRISPR Single Base Editor Revenue by Geographic Area in 2024
11.5.8 CRISPR Single Base Editor SWOT Analysis
11.5.9 CRISPR Recent Developments
11.6 GenKOre
11.6.1 GenKOre Corporation Information
11.6.2 GenKOre Business Overview
11.6.3 GenKOre Single Base Editor Product Features and Attributes
11.6.4 GenKOre Single Base Editor Revenue and Gross Margin (2020-2025)
11.6.5 GenKOre Recent Developments
11.7 Genassisttx
11.7.1 Genassisttx Corporation Information
11.7.2 Genassisttx Business Overview
11.7.3 Genassisttx Single Base Editor Product Features and Attributes
11.7.4 Genassisttx Single Base Editor Revenue and Gross Margin (2020-2025)
11.7.5 Genassisttx Recent Developments
11.8 HuidaGene
11.8.1 HuidaGene Corporation Information
11.8.2 HuidaGene Business Overview
11.8.3 HuidaGene Single Base Editor Product Features and Attributes
11.8.4 HuidaGene Single Base Editor Revenue and Gross Margin (2020-2025)
11.8.5 HuidaGene Recent Developments
11.9 CorrectSequence Therapeutics
11.9.1 CorrectSequence Therapeutics Corporation Information
11.9.2 CorrectSequence Therapeutics Business Overview
11.9.3 CorrectSequence Therapeutics Single Base Editor Product Features and Attributes
11.9.4 CorrectSequence Therapeutics Single Base Editor Revenue and Gross Margin (2020-2025)
11.9.5 CorrectSequence Therapeutics Recent Developments
12 Single Base EditorIndustry Chain Analysis
12.1 Single Base Editor Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Single Base Editor Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Single Base Editor Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Single Base Editor Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Single Base Editor Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Single Base Editor Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Single Base Editor Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Single Base Editor Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Single Base Editor Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Single Base Editor Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Single Base Editor by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Base Editor as of 2024)
Table 11. Global Single Base Editor Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Single Base Editor Companies Headquarters
Table 13. Global Single Base Editor Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Single Base Editor Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Single Base Editor Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Single Base Editor Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Single Base Editor Revenue by Application (2026-2031) & (US$ Million)
Table 21. Single Base Editor High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Single Base Editor Growth Accelerators and Market Barriers
Table 25. North America Single Base Editor Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Single Base Editor Growth Accelerators and Market Barriers
Table 27. Europe Single Base Editor Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Single Base Editor Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Single Base Editor Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Single Base Editor Investment Opportunities and Key Challenges
Table 31. Central and South America Single Base Editor Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Single Base Editor Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Single Base Editor Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Beam Therapeutics Corporation Information
Table 35. Beam Therapeutics Description and Major Businesses
Table 36. Beam Therapeutics Product Features and Attributes
Table 37. Beam Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Beam Therapeutics Revenue Proportion by Product in 2024
Table 39. Beam Therapeutics Revenue Proportion by Application in 2024
Table 40. Beam Therapeutics Revenue Proportion by Geographic Area in 2024
Table 41. Beam Therapeutics Single Base Editor SWOT Analysis
Table 42. Beam Therapeutics Recent Developments
Table 43. Verve Corporation Information
Table 44. Verve Description and Major Businesses
Table 45. Verve Product Features and Attributes
Table 46. Verve Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Verve Revenue Proportion by Product in 2024
Table 48. Verve Revenue Proportion by Application in 2024
Table 49. Verve Revenue Proportion by Geographic Area in 2024
Table 50. Verve Single Base Editor SWOT Analysis
Table 51. Verve Recent Developments
Table 52. Intellia Corporation Information
Table 53. Intellia Description and Major Businesses
Table 54. Intellia Product Features and Attributes
Table 55. Intellia Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Intellia Revenue Proportion by Product in 2024
Table 57. Intellia Revenue Proportion by Application in 2024
Table 58. Intellia Revenue Proportion by Geographic Area in 2024
Table 59. Intellia Single Base Editor SWOT Analysis
Table 60. Intellia Recent Developments
Table 61. Prime Medicine Corporation Information
Table 62. Prime Medicine Description and Major Businesses
Table 63. Prime Medicine Product Features and Attributes
Table 64. Prime Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Prime Medicine Revenue Proportion by Product in 2024
Table 66. Prime Medicine Revenue Proportion by Application in 2024
Table 67. Prime Medicine Revenue Proportion by Geographic Area in 2024
Table 68. Prime Medicine Single Base Editor SWOT Analysis
Table 69. Prime Medicine Recent Developments
Table 70. CRISPR Corporation Information
Table 71. CRISPR Description and Major Businesses
Table 72. CRISPR Product Features and Attributes
Table 73. CRISPR Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. CRISPR Revenue Proportion by Product in 2024
Table 75. CRISPR Revenue Proportion by Application in 2024
Table 76. CRISPR Revenue Proportion by Geographic Area in 2024
Table 77. CRISPR Single Base Editor SWOT Analysis
Table 78. CRISPR Recent Developments
Table 79. GenKOre Corporation Information
Table 80. GenKOre Description and Major Businesses
Table 81. GenKOre Product Features and Attributes
Table 82. GenKOre Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. GenKOre Recent Developments
Table 84. Genassisttx Corporation Information
Table 85. Genassisttx Description and Major Businesses
Table 86. Genassisttx Product Features and Attributes
Table 87. Genassisttx Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Genassisttx Recent Developments
Table 89. HuidaGene Corporation Information
Table 90. HuidaGene Description and Major Businesses
Table 91. HuidaGene Product Features and Attributes
Table 92. HuidaGene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. HuidaGene Recent Developments
Table 94. CorrectSequence Therapeutics Corporation Information
Table 95. CorrectSequence Therapeutics Description and Major Businesses
Table 96. CorrectSequence Therapeutics Product Features and Attributes
Table 97. CorrectSequence Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. CorrectSequence Therapeutics Recent Developments
Table 99. Raw Materials Key Suppliers
Table 100. Distributors List
Table 101. Market Trends and Market Evolution
Table 102. Market Drivers and Opportunities
Table 103. Market Challenges, Risks, and Restraints
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Single Base Editor Product Picture
Figure 2. Global Single Base Editor Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Adenine Base Editor Product Picture
Figure 4. Cytosine Base Editor Product Picture
Figure 5. Other Product Picture
Figure 6. Global Single Base Editor Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Gene Therapy
Figure 8. Animal and Plant Breeding Improvement
Figure 9. Basic Research
Figure 10. Other
Figure 11. Single Base Editor Report Years Considered
Figure 12. Global Single Base Editor Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 14. Global Single Base Editor Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Single Base Editor Revenue Market Share by Region (2020-2031)
Figure 16. Global Single Base Editor Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Adenine Base Editor Revenue Market Share by Player in 2024
Figure 19. Cytosine Base Editor Revenue Market Share by Player in 2024
Figure 20. Other Revenue Market Share by Player in 2024
Figure 21. Global Single Base Editor Revenue Market Share by Type (2020-2031)
Figure 22. Global Single Base Editor Revenue Market Share by Application (2020-2031)
Figure 23. North America Single Base Editor Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players Single Base Editor Revenue (US$ Million) in 2024
Figure 25. North America Single Base Editor Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America Single Base Editor Revenue (US$ Million) by Application (2020-2031)
Figure 27. US Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 28. Canada Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 30. Europe Single Base Editor Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players Single Base Editor Revenue (US$ Million) in 2024
Figure 32. Europe Single Base Editor Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe Single Base Editor Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 35. France Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 37. Italy Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 38. Russia Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Single Base Editor Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players Single Base Editor Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific Single Base Editor Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific Single Base Editor Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 44. Japan Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 46. Australia Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 47. India Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore Single Base Editor Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America Single Base Editor Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players Single Base Editor Revenue (US$ Million) in 2024
Figure 55. Central and South America Single Base Editor Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America Single Base Editor Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil Single Base Editor Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina Single Base Editor Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa Single Base Editor Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players Single Base Editor Revenue (US$ Million) in 2024
Figure 61. South America Single Base Editor Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa Single Base Editor Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries Single Base Editor Revenue (2020-2025) & (US$ Million)
Figure 64. Israel Single Base Editor Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt Single Base Editor Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa Single Base Editor Revenue (2020-2025) & (US$ Million)
Figure 67. Single Base Editor Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
